ED
LMT icon

Exane Derivatives’s Lockheed Martin LMT Stock Holding History

Exane Derivatives’s Portfolio LMT Stock Details LMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$98.9K Buy
230
+1
+0.4% +$439 0.06% 265
2022
Q1 		$101K Sell
229
-411
-64% -$167K 0.03% 472
2021
Q4 		$227K Sell
640
-227
-26% -$78.5K 0.06% 316
2021
Q3 		$299K Sell
867
-841
-49% -$304K 0.07% 286
2021
Q2 		$645K Sell
1,708
-16
-0.9% -$6.15K 0.15% 140
2021
Q1 		$637K Buy
1,724
+1,620
+1,558% +$556K 0.18% 120
2020
Q4 		$36.9K Sell
104
-3,903
-97% -$1.43M 0.01% 481
2020
Q3 		$1.54M Buy
4,007
+2,890
+259% +$1.1M 0.44% 44
2020
Q2 		$408K Sell
1,117
-427
-28% -$161K 0.11% 166
2020
Q1 		$523K Buy
1,544
+3
+0.2% +$1.18K 0.15% 122
2019
Q4 		$649K Sell
1,541
-229
-13% -$87.9K 0.12% 135
2019
Q3 		$690K Sell
1,770
-426
-19% -$160K 0.12% 131
2019
Q2 		$798K Sell
2,196
-1,861
-46% -$623K 0.14% 116
2019
Q1 		$1.22M Buy
4,057
+512
+14% +$150K 0.24% 93
2018
Q4 		$928K Sell
3,545
-104
-3% -$31.6K 0.17% 127
2018
Q3 		$1.26M Buy
3,649
+3,648
+364,800% +$1.18M 0.24% 94
2018
Q2 		$298 Hold
1
– – ﹤0.01% 583
2018
Q1 		$336 Hold
1
– – ﹤0.01% 524
2017
Q4 		$321 Sell
1
-1
-50% -$315 ﹤0.01% 515
2017
Q3 		$620 Sell
2
-295
-99% -$88K ﹤0.01% 471
2017
Q2 		$82.4K Buy
297
+296
+29,600% +$81.3K 0.02% 289
2017
Q1 		$268 Hold
1
– – ﹤0.01% 454
2016
Q4 		$250 Hold
1
– – ﹤0.01% 504
2016
Q3 		$240 Hold
1
– – ﹤0.01% 507
2016
Q2 		$248 Hold
1
– – ﹤0.01% 445
2016
Q1 		$221 Hold
1
– – ﹤0.01% 500
2015
Q4 		$217 Sell
1
-2,109
-100% -$458K ﹤0.01% 431
2015
Q3 		$437K Buy
+2,110
New +$429K 0.06% 133

Other funds holding LMT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exane Derivatives's LMT Position: Q2 2022 in Review

Exane Derivatives increased its Lockheed Martin (LMT) stake by 0.44% in Q2 2022, buying an estimated $439 and bringing the position to 230 shares worth $98.9K. The position accounts for 0.06% of the portfolio, ranked #265.

Exane Derivatives first reported a position in LMT in Q3 2015 and has held it in 28 quarters since. The position peaked at $1.54M in Q3 2020. 2,180 funds tracked by Wall St. Rank hold LMT as of Q2 2022.

  • Exane Derivatives held 230 shares of Lockheed Martin worth $98.9K as of Q2 2022.
  • Exane Derivatives bought 1 Lockheed Martin share in Q2 2022, an estimated $439.
  • Lockheed Martin made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #265 holding.
  • Exane Derivatives first reported a position in Lockheed Martin in Q3 2015 and has held it in 28 quarters since.
  • Exane Derivatives's Lockheed Martin position peaked at $1.54M in Q3 2020.
  • 2,180 funds tracked by Wall St. Rank held Lockheed Martin as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.